Janux Therapeutics Inc.

NASDAQ: JANX · Real-Time Price · USD
23.59
-1.31 (-5.26%)
At close: Jun 16, 2025, 3:59 PM
24.39
3.39%
After-hours: Jun 16, 2025, 07:44 PM EDT
-5.26%
Bid 23.51
Market Cap 1.4B
Revenue (ttm) 9.34M
Net Income (ttm) -77.74M
EPS (ttm) -1.36
PE Ratio (ttm) -17.35
Forward PE -10.03
Analyst Buy
Ask 24.39
Volume 560,501
Avg. Volume (20D) 968,207
Open 25.22
Previous Close 24.90
Day's Range 23.55 - 25.50
52-Week Range 22.48 - 71.71
Beta 2.96

About JANX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol JANX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for JANX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
6 months ago
+11.64%
Janux Therapeutics shares are trading higher after... Unlock content with Pro Subscription
6 months ago
+48.98%
Janux Therapeutics shares are trading higher after the company announced updated interim clinical data for its JANX007 program in prostate cancer.